Pill could spare young women from liver surgery
NCT ID NCT06490757
Summary
This study is testing whether a short course of the drug baricitinib can shrink large, inflammatory benign liver tumors in young women. The goal is to see if this treatment can reduce tumor size enough to avoid the need for liver surgery, which carries risks and scarring. Researchers will monitor 25 participants using MRI scans over 6 months to measure tumor response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY HEPATOCELLULAR ADENOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NAULT
RECRUITINGBobigny, 93000, France
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.